Viewing Study NCT00002160


Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2026-03-06 @ 11:54 AM
Study NCT ID: NCT00002160
Status: COMPLETED
Last Update Posted: 2005-06-24
First Post: 1999-11-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Multicenter Phase II/III, Placebo-Controlled Study of SNX-111 Administered Intrathecally to Cancer and AIDS Patients With Chronic Pain
Sponsor: Neurex
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infections View
None Cancer View
None Pain View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Acquired Immunodeficiency Syndrome View
None AIDS-Related Complex View
None Pain View
None Palliative Care View
None omega-conopeptide MVIIA View
None Calcium Channel Blockers View